Yieldmax Mrna Option Income Strategy ETF (MRNY) Quote

They have the results from the 5,,, expanding from 30 to 50,,, I'd say thats a lot of results for the FDA, An 80% reduction in tumor size and metastatic activity in 1 patient after 30 days! That's huge!,,,, Talk about efficacy.

Trump's Crypto Czar, David Sacks, to host press conference tomorrow on securing America's leadership in the Digital Asset ecosystem.

Trump's Crypto Czar, David Sacks, to host press conference tomorrow on securing America's leadership in the Digital Asset ecosystem.

China just retaliated with imposing Tariffs on US Coal and Natural Gas. Futures are red, definitely not as bad as yesterday and it will work itself out.

Sounds like it can happen at any time:

“Additionally, as results emerge, they will be shared with the FDA to further support RadioGel®’s safety profile and reinforce our Investigational Device Exemption (IDE) submission and advance expanded indications for use in the United States.”

This is interesting:

https://bsky.app/profile/johnfugelsang.bsky.social/post/3lhcl5kbiyc2h

I think the moderators should sticky this post, or the Law Review document within it.

A great deal of what's happened to NWBO has been exposed in detail by this and the Bamboo lounge article. Hopefully this is the precursor to the actual legal action occurring, and the UK regulators

Asked & answered on Borgers. They were the auditors in mid-June '23, and likely for the Form 10. Seeing the print rang a bell.

I've said my piece enough times. Come August, it trades or it don't. Can't say I don't care or that I believe there is some hidden powerhouse awaiting, but I

Anything just to argue, eh? WRONG question to ask your AI... again.

Did you even look up the 10-K? You lazy argumentative faker!

Maybe the CONSOLIDATED STATEMENTS OF OPERATIONS are not the audited part of the audited part of the 10-K.

Or, maybe they are.

Press Release February 4, 2025 Vivos Inc. Reports Encouraging Human Clinical Trial Results and
Announces Expansion Plans
Statement from Vivos CEO, Dr. Michael Korenko (Richland, WA - February 4, 2025) - Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstr

Sorry wrong board.

and the news is going to get better and better with each new release

Only thing you have been planting are weeds.....
Useless, veiled, obfuscations
Figured U were talking abt 50 day moving averages !
Not the 2.50 that I've been featuring for months

https://investorshub.advfn.com/uimage/uploads/2025/2/4/cvphkXRP_!_12_45d_6pm_GLITCH_

USAID funds the darkest projects known to mankind. Here’s a shortlist:

https://x.com/MikeBenzCyber/status/1886569998497313139

I used to use it on Tos >
I have something I like better coded up that is similar and Always have open >
One thing I found with TTM > It can get you in trouble
It likes smaller time frames (for me daily is not even an option)
It likes AHs and PRE added for resolution > A

The White House is Green tonight

https://x.com/merissahansen17/status/1886625021713395986

Sorry, forgot to thank you for that post, we - I needed that. If just to keep from getting morose.

But something I'm thinking is our economy is very strong right now and so is the markets. The markets need some sort of realistic correction to the low side, but I feel our markets and e

Two airport employees arrested for leaking the video footage of the D.C. collision last week to CNN.

https://x.com/CollinRugg/status/1886572416257650904

Los Angeles voted for this

https://x.com/EndWokeness/status/1886657705579811301

RITE ready to go atomic

[yt]QE-VAFsP89U[/yt]

Back at ya!

https://x.com/BBCBreaking/status/1886659564344397950?s=19

Wow - big news - safety in five patients. Reduced tumor 80% in one patient. Looking to expand trial to 50 ppl. Looking for manufacturing partners in India.

Vivos Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion Plans

(Richland, WA – Februar

After completing the detailed assessment of the available data from the patients, the results will be
presented to the Ethics Committee. The lead investigator intends to request authority to increase the
study from 30 patients to 50 patients. The expanded trial will provide valuable da

(Richland, WA – February 4, 2025) – Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five
patients demonstrated the safety of RadioGel Precision Radionuclide TherapyTM by satisfying the criteria
in the Clinical Study Plan, including confirmation via PET imaging that the Y-9